The Impact of ROTO Track® in Helping Patients With Diabetes Rotate Their Insulin Injections Better
NCT03407677 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2021-03-03
Summary
The ROTO track® is an electronic injection form and injection log for keeping track of injection sites in the abdominal region. The device attaches directly to the insulin pen and activates whenever the insulin pen is picked up. Small LED lights on the device will indicate where the next injection site is according to the individual patient's injection plan. By moving the pen and device to an "anchor point" in front of the navel, the device is able to start tracking where the insulin pen is being moved to. The device additionally contains a haptic interface to indicate to the user when the device has been moved to the next area in the injection plan.
The device registers the location, the time and the dosage automatically when the patient injects insulin with the pen
The rationale of the trial is that the ROTO track® can help patients rotate their injections sites and that this will provide the healthcare system with a new cost-effective tool for improving insulin injection techniques.
Conditions
Interventions
- DEVICE
-
ROTO track®
An electronic injection form and injection log for keeping track of injection sites in the abdominal region. The device attaches directly to the insulin pen and activates whenever the insulin pen is picked up.
Sponsors & Collaborators
-
Peter Lommer
lead OTHER
Principal Investigators
-
Peter L Kristensen, MD, PhD · Department of Clinical Research, Nordsjællands Hospital
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-27
- Primary Completion
- 2019-11-20
- Completion
- 2019-11-27
Countries
- Denmark
Study Locations
More Related Trials
-
A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)
NCT03367390 ·Status: COMPLETED ·Phase: PHASE1
-
Use of the Paradigm 722 System to Improve Glycemic Control in Adult and Adolescent Subjects With Type 1 Diabetes
NCT00211510 ·Status: COMPLETED ·Phase: NA
-
Insulin Degludec Titration Using Mobile Insulin Dosing System
NCT03091712 ·Status: COMPLETED ·Phase: NA
-
Study of Insulin Therapy Augmented by Real Time Sensor IN Type 1 Children and Adolescents (START-IN!)
NCT00949221 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of LY900027 Given by Insulin Pump to Participants With Type 1 Diabetes Mellitus
NCT04161976 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Novel Trend Arrow Adjustment Tool for Diabetes Patients Using Continuous Glucose Monitoring to Guide Insulin Bolus Adjustment (TAAT Study)
NCT02064647 ·Status: COMPLETED ·Phase: NA
-
Impact of a built-in Insulin Calculator Feature on Diabetes Control - Pilot Study
NCT01519466 ·Status: COMPLETED ·Phase: NA
-
Clinical Startup of the 670G Closed Loop Insulin Delivery System
NCT03017482 ·Status: COMPLETED
-
Reliability of Insulin by Jet Injection
NCT02272296 ·Status: COMPLETED ·Phase: PHASE4
-
Medtronic Treat to Range (TTR) Closed-Loop Control
NCT01490151 ·Status: COMPLETED ·Phase: NA
-
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
NCT04585776 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term CGM Treatment in Patients With Type 1 Diabetes Treated With Insulin Injections
NCT02465411 ·Status: COMPLETED ·Phase: NA
-
A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes
NCT03433677 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
NCT03849612 ·Status: COMPLETED ·Phase: NA
-
Research Study to Look at Fast-acting Insulin Aspart With the Insulin Pump System 'iLet™' in Adults With Type 1 Diabetes
NCT03816761 ·Status: COMPLETED ·Phase: PHASE2
-
Syringes Replacement for Insulin Application for Pens Device in a Population of Elderly Patients With Type 2 Diabetes: Multifactorial Intervention to Improve Glycemic Control
NCT02517242 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of the Hypoglycaemia Notification Device Hyposafe H02
NCT02925676 ·Status: TERMINATED ·Phase: NA
-
Study of MiniMed™ 640G Insulin Pump With SmartGuard™ in Prevention of Low Glucose Events in Adults With Type 1 Diabetes
NCT02733991 ·Status: COMPLETED ·Phase: NA
-
Adult Accuracy Study of the Enlite 3 Glucose Sensor
NCT02246582 ·Status: COMPLETED ·Phase: NA
-
Automated Insulin Delivery in Type 1 Diabetes Complicated by Gastroparesis
NCT05795309 ·Status: UNKNOWN ·Phase: NA
-
A Study of LY900014 in a Medtronic Pump
NCT03760640 ·Status: COMPLETED ·Phase: PHASE2
-
Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes
NCT04764968 ·Status: COMPLETED ·Phase: PHASE2
-
Automated Insulin Delivery Versus Usual Insulin Treatment Modality Before and During Pregnancy in Women With Type 1 Diabetes
NCT07240012 ·Status: RECRUITING ·Phase: NA
-
The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections
NCT06311019 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Use of an Automated Insulin Delivery System Compared to Sensor Augmented Pump at Patients With Type 1 Diabetes (T1D)
NCT02636491 ·Status: COMPLETED ·Phase: NA